Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancer|May 29, 2023
A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomasJiyun Lee, Sehhoon Park, Hyun Ae Jung, et al.
Cancer Research and Treatment|April 13, 2023
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel ChemotherapyYoung-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, et al.
Cancer Research and Treatment|July 3, 2025
Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)Yoon-Koo Kang, Min-Hee Ryu, Do-Youn Oh, et al.
Expert Opinion on Biological Therapy|April 26, 2024
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance studyMin Ho Park, Jae Hong Seo, Jung Ho Park, et al.
Therapeutic Advances in Medical Oncology|September 23, 2021
Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)Hye Sook Han, Bum Jun Kim, Hee-Jung Jee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2023
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH TrialBhumsuk Keam, Min Hee Hong, Seong Hoon Shin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 9, 2013
A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesicsHye-Suk Han, Ki Hyeong Lee, Kyung Hee Lee, et al.
BMC Cancer|February 23, 2024
Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)Sung Hee Lim, Keun-Wook Lee, Jae-Joon Kim, et al.
The Oncologist|September 8, 2019
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin ToxicitiesYoung Saing Kim, Jun Ho Ji, Sung Yong Oh, et al.
Theranostics|June 6, 2022
Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automationHyeong Jung Woo, Seung-Hoon Kim, Hyo Jung Kang, et al.
Pageof 6